000 | 01568 a2200433 4500 | ||
---|---|---|---|
005 | 20250510205907.0 | ||
264 | 0 | _c19751211 | |
008 | 197512s 0 0 eng d | ||
022 | _a0310-057X | ||
024 | 7 |
_a10.1177/0310057X7500300303 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFisher, M M | |
245 | 0 | 0 |
_aSevere histamine mediated reactions to intravenous drugs used in anaesthesia. _h[electronic resource] |
260 |
_bAnaesthesia and intensive care _cAug 1975 |
||
300 |
_a180-97 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article; Review | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAlfaxalone Alfadolone Mixture _xadverse effects |
650 | 0 | 4 |
_aAnaphylaxis _xchemically induced |
650 | 0 | 4 |
_aAnesthesia, Intravenous _xadverse effects |
650 | 0 | 4 |
_aAnesthetics _xadverse effects |
650 | 0 | 4 | _aAntigen-Antibody Reactions |
650 | 0 | 4 |
_aDrug Hypersensitivity _xetiology |
650 | 0 | 4 | _aFalse Negative Reactions |
650 | 0 | 4 | _aFalse Positive Reactions |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHistamine H1 Antagonists _xpharmacology |
650 | 0 | 4 | _aHistamine Release |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeuromuscular Nondepolarizing Agents _xadverse effects |
650 | 0 | 4 |
_aPropanidid _xadverse effects |
650 | 0 | 4 | _aSkin Tests |
650 | 0 | 4 |
_aSuccinylcholine _xadverse effects |
650 | 0 | 4 |
_aThiopental _xadverse effects |
773 | 0 |
_tAnaesthesia and intensive care _gvol. 3 _gno. 3 _gp. 180-97 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/0310057X7500300303 _zAvailable from publisher's website |
999 |
_c51218 _d51218 |